A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses

Journal of Peptide Science

Volumn 2, Issue 3, 1996, Pages 165-175

  Estaquier, Jérôme ^a,b   Boutillon, Christophe ^a   Georges, Bertrand ^a   Ameisen, Jean Claude ^a   Tartar, André ^a   Auriault, Claude ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Cytokines; HIV; Immune response; Peptide library

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; MURINAE;

AMINO ACID; CYTOKINE; GLYCOPROTEIN GP 120; HIV ENVELOPE PROTEIN GP120 (305 321); HIV ENVELOPE PROTEIN GP120 (305-321); PEPTIDE FRAGMENT; PEPTIDE LIBRARY; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL; ANTIGENIC VARIATION; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CBA MOUSE; CHEMISTRY; DRUG EFFECT; FEMALE; FISCHER 344 RAT; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; MOUSE; PROTEIN TERTIARY STRUCTURE; RAT; SECRETION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENIC VARIATION; B-LYMPHOCYTES; CYTOKINES; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV-1; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, INBRED F344; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0030132546     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.54     Document Type: Article

References (61)

1. D. J. Rowlands, B. E. Clarke, A. R. Caroll, F. Brown, B. H. Nicholson, J. L. Bittle, R. A. Houghten and R. A. Lerner (1983). Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature 306, 694-697.
2. H. Alexander, D. A. Johnson, J. Rosen, L. Jerabek, N. Green, I. L. Weissman and R. A. Lerner (1983) Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids. Nature 306, 697-699.
3. E. D. Getzoff, H. M. Geysen, S. J. Rodda, H. Alexander, J. A. Tainer and R. A. Lerner (1987). Mechanisms of antibody binding to a protein. Science 235, 1191-1196.
4. E. R. Unanue (1984). Antigen-presenting function of the macrophage. Ann. Rev. Immunol. 2, 395-428.
5. R. H. Schwartz (1986). Immune response (Ir) genes of the murine major histocompatibility complex. Adv. Immunol. 38, 31-201.
6. S. Buus, A. Sette, H. M. Grey (1987). The interaction between protein-derived immunogenic peptides and Ia. Immunol. Rev. 98, 115-141.
7. P. Allen, G. Matsueda, R. Evans, J. Dunbar, G. Marshall and E. Unanue (1987). Identification of the T-cell and Ia contact residues of T-cell antigenic epitope. Nature 327, 713-715.
8. B. Fox, C. Chen, E. Fraga, C. A. French, B. Singh and R. H. Schwartz (1987). Functionally distinct agretopic and epitopic sites. J. Immunol. 139, 1578-1588.
9. A. Sette, S. Buus, S. Colon, J. Smith, C. Miles and H. Grey (1987). Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328, 395-397.
10. D. Millich, J. Hughes, R. Houghten, A. McLachlan and J. Jones (1989). Functional identification of agretopic and epitopic residues within an HBcAg T cell determinant. J. Immunol. 143, 3141-3147.
11. M. A. Brown, L. A. Glimcher, E. A. Nielsen, W. Paul and R. Germain (1986). T cell recognition of Ia molecules selectively altered by a single amino acid substitution. Science 231, 255-258.
12. D. Hansburg, T. Fairwell, R. H. Schwartz and E. Appella (1983). The T lymphocyte response to cytochrome C. J. Immunol. 131, 319-324.
13. kβ chain residues in presentation of a peptide from myelin basic protein. J. Exp. Med. 169, 2239-2244.
14. β modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic protein. J. Immunol. 143, 2083-2093.
15. α-chain. J. Immunol. 143, 1472-1481.
16. F. L. Norton, C. B. Davis, P. P. Jones and J. W. Goodman (1989). Arsonate-specific murine T cell clones. J. Immunol. 143, 446-451.
17. k polymorphisms define a functionally dominant region for the presentation of hen egg lysosyme peptides. J. Immunol. 143, 50-58.
18. J. I. Krieger, R. W. Karr, H. M. Grey, W. -Y. Yu, D. O'Sullivan, L. Batovsky, Z. -L. Zheng, S. M. Colon, F. C. A. Gaeta, J. Sidney, M. Albertson, M. F. Del Guercio, R. W. Chestnut and A. Sette (1991). Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146, 2331-2340.
19. R. W. Karr, W. -Y. Yu, R. Watts, K. S. Evans and E. Celis (1990). The role of polymorphic HLA-DRβ chain residues in presentation of viral antigens to T cells. J. Exp. Med. 172, 273-283.
20. P. J. Bjorkman, M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger and D. C. Wiley (1987). Structure of the human class I histocompatibility antigen HLA-A2. Nature 329, 506-511.
21. J. Brown, T. Jardetzky, J. Gorga, L. Stern, R. Urban, J. Strominger and D. Wiley (1993). Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
22. K. Falk, O. Rötzschke, S. Stevanovic, G. Jung and H. - G. Rammensee (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
23. H. Kropshofer, H. Max, C. Müller, F. Hesse, S. Stevanovic, G. Jung and H. Kalbacher (1992). Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J. Exp. Med. 175, 1799-1803.
24. P. Romero, G. Corradin, I. Luescher and J. Maryanski (1991). H-2Kd-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174, 603-612.
25. D. R. Madden, J. C. Gorga, J. L. Strominger and D. C. Wiley (1992). The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035-1048.
26. S. E. Buxton, R. J. Benjamin, C. Clayberger, P. Parham and A. M. Krensky (1992). Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: Analysis of the conserved B ("45") pocket of HLA-B27. J. Exp. Med. 175, 809-820.
27. M. Matsumara, D. Fremont, P. Peterson and I. Wilson (1992). Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257: 927-934.
28. F. Latron, L. Pazmany, J. Morrison, R. Moots, M. Saper, A. McMichael and J. Strominger (1992). A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science 257, 964-967.
29. R. J. Orentas, J. E. K. Hildreth, E. Obah, M. Polydefkis, G. E. Silver, H. -C. Guo, J. L. Strominger and D. C. Wiley (1992). Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 360, 367-369.
30. + human cytolytic T cells specific for HIV-infected cells by a gp 160 subunit vaccine. Science 248, 1234-1237.
31. + cytotoxic T cells by immunization with purified HIV-1 envelope protein, in ISCOMs. Nature 344, 873-875.
32. A. Hoffenbach, P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran and F. Plata (1989). Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142, 452-462.
33. K. Javaherian, A. J. Langlois, C. McDanal, K. L. Ross, L. I. Eckler, C. L. Jellis, A. T. Profy, J. R. Rusche, D. P. Bolognesi, S. D. Putney and T. J. Matthews (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl Acad. Sci. USA 86, 6768-6772.
34. J. Goudsmit, C. Debouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs and D. C. Gajdusek (1988). Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl Acad. Sci. USA 85, 4478-4482.
35. J. R. Rusche, K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, P. J. Fischinger, D. P. Bolognesi, S. D. Putney and T. J. Matthews (1988). Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp 120. Proc. Natl Acad. Sci. USA 85, 3198-3202.
36. H. Takahashi, J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. L. Cornette, C. DeLisi, B. Moss, R. N. Germain and J. A. Berzofsky (1988). An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp 160 recognized by class 1 major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl Acad. Sci. USA 85, 3105-3109.
37. F. Manca, J. A. Habeshaw, A. G. Dalgleish, D. Fenoglio, G. Li Pira and E. E. Sercarz (1993). Role of flanking variable sequences in antigenicity of consensus regions of HIV gp 120 for recognition by specific human T helper clones. Eur. J. Immunol. 23, 269-274.
38. T. Shioda, J. A. Levy and C. Chen-Mayer (1992). Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 89, 9434-9438.
39. H. Gras-Masse, J. -C. Ameisen, C. Boutillon, F. Rouaix, M. Bossus, B. Deprez, J. -L. Neyrinck, A. Capron and A. Tartar (1992). Synthesis vaccines and HIV-1 hypervariability: A 'mixotope' approach. Peptide Res. 5, 4.
40. T. Masuda, S. Matsushita, M. J. Kuroda, M. Kannagi, K. Takatsuki and S. Harada (1990). Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable Env region. J. Immunol. 145, 3240-3246.
41. G. Zwart, H. Langedijk, L. Van Der Hoek, J. -J. De Long, T. F. W. Wolfs, C. Ramautarsing, M. Bakker, A. De Ronde and J. Goudsmit (1991). Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology 181, 481-489.
42. R. E. Phillips, S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza and A. J. McMichael (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459.
43. P. Klenerman, S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Glangrande, R. E. Phillips and A. J. McMichael (1994). Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369, 403-407.
44. A. Bertoletti, A. Sette, F. V. Chisari, A. Penna, M. Levrevo, M. De Carli, F. Fiaccadori and C. Ferrari (1994). Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410.
45. E. Couillin, B. Culmann-Penciolelli, E. Gomard, J. Choppin, J. -P. Levy, J. -G. Guillet and S. Sargosti (1994). Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 Nef protein. J. Exp. Med. 180, 1129-1134.
46. R. Cheynier, S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran and S. Wain-Hobson (1994). Clonal expression of T cells and HIV genotypes in microdissected splenic white pupls, indicate viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes. Cell. 78, 373-385.
47. J. L. Risler, M. O. Delorme, H. Delacroie and A. Henaut (1988). Amino acid substitutes in structurally related proteins. A pattern recognition approach. J. Molec. Biol. 204, 1019-1029.
48. J. Estaquier, H. Gras-Masse, C. Boutillon, J. -C. Ameisen, A. Capron, A. Tartar and C. Auriault (1994). The mixotope: a combinatorial peptide library as a T-cell and B-cell immunogen. Eur. J. Immunol. 24, 2789-2795.
49. + T lymphocytes. Immunol. Today 9, 268-273.
50. + T helper cell subsets. Current Opinion Immunol. 5, 391-397.
51. C. M. Graham, A. P. Warren and D. B. Thomas (1992). Do antigenic drift residues in influenza hemagglutinins of the H3 subtype qualify as contact sites for MHC class II interaction? International Immunol 4, 917-922.
52. L. Zhuoru, K. P. Williams, Y. -H. Chang and J. A. Smith (1993). Immunodominance: A single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants. J. Immunol. 151, 1852-1858.
53. J. Alexander, K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F. C. A. Gaeta, S. M. Colon, H. M. Grey and A. Sette (1993). Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol. 150, 1-7.
54. D. Ostrov, J. Krieger, J. Sidney, A. Sette and P. Concannon (1993). T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. J. Immunol. 150, 4277-4283.
55. M. T. De Magistris, J. Alexander, M. Coggeshall, A. Altman, F. C. A. Gaeta, H. M. Grey and A. Sette (1992). Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68, 625-634.
56. A. R. Neurath and N. Strick (1990). Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1). Mole. Immunol. 27, 539-549.
57. K. M. Callahan, M. M. Fort, E. A. Obah, E. L. Reinherz and R. F. Siliciano (1990). Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. J. Immunol. 144, 3341-3346.
58. L. Racioppi, F. Ronchese, L. A. Matis and R. N. Germain (1993). Peptide-major histocompatibility complex class II complexes with mixed angonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177, 1047-1060.
59. J. Sloanne-Lancaster, B. D. Evavold and P. M. Allen (1993). Induction of T-cell anergy by altered T-cell receptor ligand on live antigen-presenting cells. Nature 363, 156-159.
60. B. D. Evavold and P. M. Allen (1991). Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252, 1308-1310.
61. P. Soloway, S. Fish, H. Passmore, M. Gefter, R. Coffee and T. Manser (1991). Regulation of the immune response to peptide antigens. Differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J. Exp. Med. 174, 847-858.